ArticleDiagnostic pathology2018

MYO18B promotes hepatocellular carcinoma progression by activating PI3K/AKT/mTOR signaling pathway.

Zhenyu Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.